| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.47M | - | |
| Other | 52.8K | $8.82M | - | |
| Other | 46.8K | $7.82M | - | |
| Other | 39.6K | $6.62M | -36,937 | |
| Other | 36.8K | $6.16M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2020 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 3,438 | $102.38 | $351,990.78 | -5.1% | |
| Feb 6, 2020 | Lippoldt Darin60 | Chief Legal Officer | Sell | 2,948 | $102.36 | $301,762.67 | -4.3% | |
| Feb 6, 2020 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 9,792 | $102.41 | $1,002,793.48 | -0.8% | |
| Feb 6, 2020 | Bozigian Haig P. | Chief Development Officer | Sell | 3,441 | $102.43 | $352,448.97 | -0.8% | |
| Feb 6, 2020 | Benevich Eric62 | Chief Commercial Officer | Sell | 3,349 | $102.38 | $342,872.07 | -6.1% | |
| Feb 5, 2020 | Cooke Julie59 | Chief Human Resources Officer | Sell | 605 | $103.17 | $62,417.31 | -13.7% | |
| Jan 8, 2020 | Roberts Eiry49 | Chief Medical Officer | Sell | 2,632 | $111.11 | $292,444.94 | -30.5% | |
| Dec 2, 2019 | Abernethy Matt57 | Chief Financial Officer | Sell | 1,645 | $116.33 | $191,360.38 | -29.8% | |
| Nov 18, 2019 | Grigoriadis Dimitri E. | Chief Research Officer | Sale+OE | 5,000 | $115.98 | $579,900.00 | -4.4% | |
| Nov 8, 2019 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 10,000 | $110.01 | $1,100,057.38 | -19.9% |